234 related articles for article (PubMed ID: 9362488)
1. Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor.
Gether U; Lin S; Ghanouni P; Ballesteros JA; Weinstein H; Kobilka BK
EMBO J; 1997 Nov; 16(22):6737-47. PubMed ID: 9362488
[TBL] [Abstract][Full Text] [Related]
2. Examination of ligand-induced conformational changes in the beta2 adrenergic receptor.
Kobilka B; Gether U; Seifert R; Lin S; Ghanouni P
Life Sci; 1998; 62(17-18):1509-12. PubMed ID: 9585127
[TBL] [Abstract][Full Text] [Related]
3. Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta 2 adrenergic receptor mapped by site-selective fluorescent labeling.
Jensen AD; Guarnieri F; Rasmussen SG; Asmar F; Ballesteros JA; Gether U
J Biol Chem; 2001 Mar; 276(12):9279-90. PubMed ID: 11118431
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes.
Gether U; Lin S; Kobilka BK
J Biol Chem; 1995 Nov; 270(47):28268-75. PubMed ID: 7499324
[TBL] [Abstract][Full Text] [Related]
5. Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor.
Yao X; Parnot C; Deupi X; Ratnala VR; Swaminath G; Farrens D; Kobilka B
Nat Chem Biol; 2006 Aug; 2(8):417-22. PubMed ID: 16799554
[TBL] [Abstract][Full Text] [Related]
6. Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor.
Ghanouni P; Steenhuis JJ; Farrens DL; Kobilka BK
Proc Natl Acad Sci U S A; 2001 May; 98(11):5997-6002. PubMed ID: 11353823
[TBL] [Abstract][Full Text] [Related]
7. Examination of ligand-induced conformational changes in the beta 2-adrenergic receptor by fluorescence spectroscopy.
Kobilka BK; Gether U
Adv Pharmacol; 1998; 42():470-3. PubMed ID: 9327941
[No Abstract] [Full Text] [Related]
8. Agonist-induced conformational changes in the beta2 adrenergic receptor.
Kobilka BK
J Pept Res; 2002 Dec; 60(6):317-21. PubMed ID: 12464109
[No Abstract] [Full Text] [Related]
9. Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility.
Gether U; Ballesteros JA; Seifert R; Sanders-Bush E; Weinstein H; Kobilka BK
J Biol Chem; 1997 Jan; 272(5):2587-90. PubMed ID: 9006889
[TBL] [Abstract][Full Text] [Related]
10. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
Bhattacharya S; Hall SE; Vaidehi N
J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
[TBL] [Abstract][Full Text] [Related]
11. Mutation of a single TMVI residue, Phe(282), in the beta(2)-adrenergic receptor results in structurally distinct activated receptor conformations.
Chen S; Lin F; Xu M; Riek RP; Novotny J; Graham RM
Biochemistry; 2002 May; 41(19):6045-53. PubMed ID: 11993999
[TBL] [Abstract][Full Text] [Related]
12. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.
Kikkawa H; Kurose H; Isogaya M; Sato Y; Nagao T
Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239
[TBL] [Abstract][Full Text] [Related]
13. Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states.
Swaminath G; Xiang Y; Lee TW; Steenhuis J; Parnot C; Kobilka BK
J Biol Chem; 2004 Jan; 279(1):686-91. PubMed ID: 14559905
[TBL] [Abstract][Full Text] [Related]
14. Mutation of Asn293 to Asp in transmembrane helix VI abolishes agonist-induced but not constitutive activity of the beta(2)-adrenergic receptor.
Hannawacker A; Krasel C; Lohse MJ
Mol Pharmacol; 2002 Dec; 62(6):1431-7. PubMed ID: 12435811
[TBL] [Abstract][Full Text] [Related]
15. Characterization of ligand-induced conformational states in the beta 2 adrenergic receptor.
Kobilka B; Gether U; Seifert R; Lin S; Ghanouni P
J Recept Signal Transduct Res; 1999; 19(1-4):293-300. PubMed ID: 10071765
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent labeling of the leukocyte NADPH oxidase subunit p47(phox): evidence for amphiphile-induced conformational changes.
Park HS; Park JW
Arch Biochem Biophys; 1998 Dec; 360(2):165-72. PubMed ID: 9851827
[TBL] [Abstract][Full Text] [Related]
17. Beta2-adrenoceptors: mechanisms of action of beta2-agonists.
Johnson M
Paediatr Respir Rev; 2001 Mar; 2(1):57-62. PubMed ID: 16263481
[TBL] [Abstract][Full Text] [Related]
18. Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling.
Manglik A; Kim TH; Masureel M; Altenbach C; Yang Z; Hilger D; Lerch MT; Kobilka TS; Thian FS; Hubbell WL; Prosser RS; Kobilka BK
Cell; 2015 May; 161(5):1101-1111. PubMed ID: 25981665
[TBL] [Abstract][Full Text] [Related]
19. FRET-based monitoring of conformational change of the beta2 adrenergic receptor in living cells.
Nakanishi J; Takarada T; Yunoki S; Kikuchi Y; Maeda M
Biochem Biophys Res Commun; 2006 May; 343(4):1191-6. PubMed ID: 16580633
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation.
Rubenstein LA; Zauhar RJ; Lanzara RG
J Mol Graph Model; 2006 Dec; 25(4):396-409. PubMed ID: 16574446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
